期刊
CURRENT OPINION IN PHARMACOLOGY
卷 7, 期 1, 页码 22-26出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2006.07.005
关键词
-
资金
- Intramural NIH HHS Funding Source: Medline
Increasing evidence suggests that bipolar disorder (BPD) is associated with regional brain volumetric reductions, accompanied by cellular atrophy and/or loss. Considerable data suggest that the protypical drugs for BPD - lithium and valproate - when administered in therapeutically relevant paradigms regulate neurotrophic signaling cascades. Notably, brain-derived neurotrophic factor, the extracellular signal-regulated kinase pathway, the glycogen synthase kinase-3-mediated pathway and Bcl-2 are major targets for mood stabilizers. Further data suggest that agents which directly target neurotrophic signaling cascades may have considerable utility for the treatment of this devastating illness.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据